Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
Fukuchi K, Koyama D, Takada M, Mori H, Hayashi K, Asano N, Sato Y, Fukatsu M, Takano M, Takahashi H, Shirado-Harada K, Kimura S, Yamamoto T, Ikezoe T. Fukuchi K, et al. Among authors: ikezoe t. Int J Hematol. 2023 Oct;118(4):489-493. doi: 10.1007/s12185-023-03597-9. Epub 2023 Apr 8. Int J Hematol. 2023. PMID: 37029861
Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y, Fukatsu M, Suzuki T, Sasajima T, Gunji N, Yoshida S, Asano N, Fukuchi K, Mori H, Takano M, Hayashi K, Takahashi H, Shirado-Harada K, Kimura S, Koyama D, Migita K, Ikezoe T. Sato Y, et al. Among authors: ikezoe t. Int J Hematol. 2023 Nov;118(5):642-646. doi: 10.1007/s12185-023-03603-0. Epub 2023 Apr 21. Int J Hematol. 2023. PMID: 37084069
Cancer-associated thrombosis in hematologic malignancies.
Fukatsu M, Ikezoe T. Fukatsu M, et al. Among authors: ikezoe t. Int J Hematol. 2024 May;119(5):516-525. doi: 10.1007/s12185-023-03690-z. Epub 2024 Jan 25. Int J Hematol. 2024. PMID: 38270784 Review.
Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.
Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, Miyairi Y, Murai K, Shimosegawa K, Yoshida K, Inokura K, Fukuhara N, Harigae H, Sato R, Ishizawa K, Tajima K, Saitou S, Fukatsu M, Ikezoe T, Tsunoda S, Mita M, Mori J, Kowata S, Ito S. Oyake T, et al. Among authors: ikezoe t. J Clin Exp Hematop. 2024 Sep 28;64(3):191-202. doi: 10.3960/jslrt.24021. Epub 2024 Jul 31. J Clin Exp Hematop. 2024. PMID: 39085129 Free PMC article.
354 results